Compare Banyan Biomarkers vs Guilford Pharmaceuticals
Customers evaluate the quality of Banyan Biomarkers's products using the following success metrics.
Overview
Banyan Biomarkers is 11 yrs old and is based in United States.
Banyan Biomarkers has created a Point of Care (POC) Blood Test to diagnose traumatic brain injury (TBI). Banyan Biomarkers' research has identified unique biomarkers present in the patient's blood following injury to the brain. The detection and quantification of these biomarkers may provide early indications of brain trauma essential for earlier intervention and management.
Guilford Pharmaceuticals is 31 yrs old and is based in United States.
Guilford Pharmaceuticals is a pharmaceutical company engaged in the research, development and commercialization of products that target the hospital market. Guilford's marketed products include the Gliadel Wafer for brain tumor treatment, and their product pipeline includes a novel anesthetic, Aquavan Injection.
Demo Video
Leadership
Ronald L Hayes (Founder, President)
Andy Jordan (Chief Financial Officer, Executive Vice President)
Investors
Paycheck Protection Program, bioMerieux
MGI Pharma, Domain Associates
Product
Benefits
Products
Customers
Known Partners
Why They Buy
Information not available because Banyan Biomarkers has not claimed their profile.
Work for Banyan Biomarkers? Claim your profile by submitting an Analyst Briefing. By submitting you can
Work for Banyan Biomarkers?
Claim your profile now.
Information not available because Guilford Pharmaceuticals has not claimed their profile.
Work for Guilford Pharmaceuticals? Claim your profile by submitting an Analyst Briefing. By submitting you can
Work for Guilford Pharmaceuticals?
Claim your profile now.